The going has been strong for Regeneron Pharmaceuticals REGN over the past six months. Shares of this biotech giant have ...

First-line treatment of advanced acral melanoma with the PD-1 inhibitor toripalimab (Loqtorzi) resulted in a small but statistically significant increase in progression-free survival (PFS) compared ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

The field of cancer treatment saw a variety of advancements in 2025, from new dedicated centers to approved treatments to ...

The Trump administration has urged the U.S. Supreme Court to hear Bayer's case aimed at stopping thousands of cancer lawsuits over its Roundup weedkiller. Bayer CEO Bill Anderson joined "The Claman ...

Dayot Upamecano’s future has been a major point of discussion in recent weeks, with his contract at Bayern Munich expiring at the end of the season. Real Madrid have emerged as a suitor for the French ...

The biotech giant is facing over 67,000 US lawsuits over allegations that its Roundup weedkiller causes cancer — a claim Bayer denies. Shares in Bayer rose over 9% during Tuesday morning trading in ...

Bayern Munich expect Dayot Upamecano to sign a new contract, with the defender in advanced talks over committing his future to the Bundesliga side. As it stands Upamecano is out of contract at the end ...

Bayer’s oral FXIa inhibitor asundexian has significantly reduced the risk of stroke in a phase 3 trial, giving a boost to a potentially blockbuster mechanism that has suffered setbacks over the past ...

Following Priority Review and Breakthrough Therapy Designation, the US Food and Drug Administration (FDA) has granted accelerated approval for Hyrnuo (sevabertinib), for the treatment of adult ...

The Food and Drug Administration (FDA) on Wednesday granted accelerated approval to Bayer AG‘s (OTC: BAYRY) Hyrnuo (sevabertinib) for adults with a specific type of advanced lung cancer. The approval ...